NCT02746900

Brief Summary

Spontaneous preterm birth (SPTB) remains the number one cause of perinatal mortality in many countries, including the United States. In singleton gestations a short cervical length (CL) on transvaginal ultrasound (TVU) has been shown to be a good predictor of SPTB. Different strategies have been adopted for prevention of SPTB. Growing interest has focused on pessary for prevention of SPTB. Cervical pessary is relatively non-invasive, easy to use, does not require anesthesia, can be used in an outpatient clinic setting, and it is easily removed when necessary. However, a recent systematic review and meta-analysis of randomized clinical trials showed that in singleton pregnancies with short cervix, prophylactic use of the pessary did not reduce the rate of spontaneous preterm delivery or improve perinatal outcome. The evidence supports the use of vaginal progesterone in singleton pregnancies with short cervix, while cervical cerclage seems to be beneficial only in the subgroup of women with both prior SPTB and TVU CL ≤25mm. Interestingly, only 235 singletons without prior SPTB,7 and 504 singletons gestations with prior SPTB,6 have been included in randomized studies on cerclage for TVU CL ≤25mm. A meta-analysis of four trials showed that cervical cerclage did not prevent SPTB in women with short TVU CL and without prior preterm birth.7 However, even if the statistical significance were not reached, they found a reduction in SPTB \<35 weeks by 16% in singletons with short TVU CL and without prior SPTB (20.6% vs 31.2%; relative risk (RR) 0.84, 95% confidence interval (CI) 0.60 to 1.17) and by 24% in singletons without risk factors for SPTB (25.6% vs 33.3%; RR 0.76, 95% CI 0.52 to 1.15). Therefore, the aim of this study is to evaluate the efficacy of cervical cerclage in prevention of SPTB in singleton pregnancies with short TVU CL in second trimester, without prior SPTB.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
587

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Apr 2016

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2016

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

April 8, 2016

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 21, 2016

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2018

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2019

Completed
Last Updated

April 21, 2016

Status Verified

April 1, 2016

Enrollment Period

2 years

First QC Date

April 8, 2016

Last Update Submit

April 18, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Spontaneous preterm birth (SPTB)

    Less than 35 weeks gestation

Secondary Outcomes (10)

  • Spontaneous preterm birth (SPTB)

    Less than 37,34,32,28 and 24 weeks gestation

  • Gestational age at delivery

    Delivery (at birth)

  • Latency

    Delivery (at birth)

  • chorioamnionitis

    Delivery (at birth)

  • Birth weight

    Delivery (at birth)

  • +5 more secondary outcomes

Study Arms (2)

Cervical cerclage

EXPERIMENTAL

After the woman is placed in the dorsal lithotomy position and the bladder is emptied with a urinary catheter to reduce the chance of bladder injury, surgical preparation with Betadine will be performed. Breisky retractors and Sims retractors will be used to exposure the entire cervix. Sponge ring forceps will be used to optimized visualization of the cervix and provide the necessary countertraction at the suture entry and exit sites. McDonald technique will be performed placing 4-6 bites circumferentially around the cervix. Only one stitch will be used. The suture will be places as high as feasible

Procedure: Cervical cerclage

No intervention

NO INTERVENTION

Bed rest will be not recommended.

Interventions

McDonald cervical cerclage

Cervical cerclage

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • ages
  • Singleton pregnancy
  • Cervical length \<=25mm between 18(0) and 23(6) weeks

You may not qualify if:

  • Multiple pregnancy
  • Prior spontaneous preterm birth or second trimester losses between 16(0) and 36(6) weeks
  • Cerclage in situ
  • Painful regular uterine contraction and/or preterm labor
  • Ruptured membranes
  • Major fetal defects
  • Active vaginal bleeding
  • Placenda previa and/or accreta
  • Cervical dilation \>1.5 cm and/or visible membranes by pelvic exam
  • Suspicion of chorioamnionitis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gabriele Saccone

Napoli, 80129, Italy

RECRUITING

MeSH Terms

Conditions

Premature Birth

Interventions

Cerclage, Cervical

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

Obstetric Surgical ProceduresSurgical Procedures, Operative

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

April 8, 2016

First Posted

April 21, 2016

Study Start

April 1, 2016

Primary Completion

April 1, 2018

Study Completion

April 1, 2019

Last Updated

April 21, 2016

Record last verified: 2016-04

Locations